For antibiotics, the right dose is restraint

📌 Summary:

• Context: A global study in The Lancet Public Health flags a worrying imbalance in India's antibiotic use — over-reliance on stronger medicines while safer first-line drugs stay underused; the issue has reached an inflection point
• Core argument: The answer to rising antimicrobial resistance (AMR) is restraint and stewardship — replacing quick-fix prescriptions with evidence-based care
• Mechanism / causal chain: The WHO classifies antibiotics into three groups — "Access" (first-line for common infections), "Watch" (broader-spectrum, to be reserved), and "Reserve" (last line against resistant infections); over-prescription of "Watch" drugs feels reassuring to patient and overstretched doctor but each unnecessary dose narrows future options; underuse of "Reserve" drugs in genuinely resistant cases is a systemic failure; fragmented delivery, poor diagnostics and liberal antibiotic use in livestock/agriculture all feed AMR
• Key data: India's optimal use estimated at 9.9–14.7 defined daily doses per 1,000 people/day, but actual use is 18.3; "Watch" antibiotics at 9.3 doses (vs recommended 6); "Access" antibiotics only 4.5 doses (well short of need)
• India's specific vulnerability: A high infectious-disease burden means antibiotics remain indispensable, making irrational use especially dangerous
• Solutions proposed: National Action Plan on AMR 2.0 (2025–2029) puts antimicrobial stewardship at the centre across human health, animal husbandry and agriculture; stricter, coordinated compliance across the pharma supply chain to curb over-the-counter sales and irrational fixed-dose combinations
• International/comparative angle: The WHO AWaRe framework and the Lancet global study anchor the argument in international best practice

🎯 UPSC Relevance: GS2 Governance & Social Justice — health policy and governance; also GS3 science/health — antimicrobial resistance as a One Health challenge.

📝 Prelims Facts:

• WHO AWaRe classification: Access, Watch, Reserve antibiotics
• India's actual antibiotic use 18.3 defined daily doses/1,000 people/day vs optimal 9.9–14.7
• National Action Plan on AMR 2.0 covers 2025–2029

🔑 Key Term: Antimicrobial resistance (AMR) — when microbes evolve to resist drugs that once killed them, making infections harder and costlier to treat; addressed through "antimicrobial stewardship" (rational, evidence-based use).